Rapid Clinical Updates: COVID-19, Coagulopathy Related Thrombotic Complications

Our panel discusses Coagulopathy Related Thrombotic Complications of COVID-19, including definitions and mechanisms including interpretation of d-dimers and when you should investigate for VTE , VTE prophylaxis in the hospital and post-hospital, and treatment of VTE. Information in this webinar is current as of December 14, 2020.

Joseph Sweigart, MD, SFHM

Margaret Fang, MD
Geoffrey Barnes, MD, MSc
Scott Kaatz, DO, MSc, SFHM


Learning Objectives

•Understand COVID-related coagulopathy, definitions and mechanisms, including interpretation of d-dimers and when to investigate for VTE.
•Evaluate the best options for assessing COVID-19 associated coagulopathy in hospitalized patients, including D-dimer, fibrinogen, platelets and PT/aPTT.
•Identify the best practices for in the hospital AND post-hospital VTE prophylaxis in patients with COVID-19.

Additional Information

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-physician
Course opens: 
Course expires: 
Your cost:

Scott Kaatz, DO, MSc, SFHM
Consultant: Janssen, Pfizer, Portola, Roche, Bristol Myer Squibb
Research funding (to institution): Janssen

Margaret Fang, MD
Grant funding: NIA, NHLBI, and PCORI
Geoffrey Barnes, MD, MSc
Grants: Blue Cross Blue Shield of Michigan, NHLBI, AHRQ
Consulting: Pfizer/Bristol-Myers Squibb, Janssen, Acelis Connected Health

Remaining faculty had no relevant financial or advisory relationships with corporate organizations related to this activity.


In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

The Society of Hospital Medicine designates this live activity, for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity

The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provider continuing medical education for physicians.

SHM is dedicated to promoting the highest quality care for all hospitalized patients. SHM is committed to promoting excellence in the practice of hospital medicine through education, advocacy and research.


Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-physician


Your cost:
Please login or register to take this course.

Click the START button to enter the meeting evaluation.